J. V. van Meel

发表

6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.

G. Mihm, U. Ries, B. Narr, 1993, Journal of medicinal chemistry.

Influence of nifedipine on functional responses in vivo initiated at alpha 2-adrenoceptors.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1983, Journal of cardiovascular pharmacology.

Pimobendan Increases Survival of Cardiomyopathic Hamsters

J. V. van Meel, W. Wienen, W. Diederen, 1989, Journal of cardiovascular pharmacology.

Selectivity of some alpha adrenoceptor agonists for peripheral alpha-1 and alpha-2 adrenoceptors in the normotensive rat.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1981, The Journal of pharmacology and experimental therapeutics.

Impairment by nifedipine of vasopressor responses to stimulation of postsynaptic alpha 2-adrenoreceptors in ganglion--blocked rabbits. Further evidence for the selective inhibition of postsynaptic alpha 2-adrenoreceptor-induced pressor responses by calcium antagonists.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1982, Journal of autonomic pharmacology.

Vascular smooth muscle contraction initiated by postsynaptic alpha 2-adrenoceptor activation is induced by an influx of extracellular calcium.

P. Timmermans, B. Wilffert, J. V. van Meel, 1981, European journal of pharmacology.

Hypotensive activity of calcium entry blockers in rats. Relationship with depression of alpha 2-adrenoceptor-mediated vasopressor responses.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1983, European journal of pharmacology.

Pharmacology of calcium entry blockers: interaction with vascular alpha-adrenoceptors.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1983, Hypertension.

Endothelium-dependent, nitric oxide-mediated inhibition of angiotensin II-induced contractions in rabbit aorta.

J. V. van Meel, M. Pfaffendorf, P. V. van Zwieten, 1994, European journal of pharmacology.

Increase in calcium sensitivity of cardiac myofibrils contributes to the cardiotonic action of sulmazole.

R. Zimmermann, J. V. van Meel, E. Erdman, 1988, Biochemical pharmacology.

alpha 1- and alpha 2-adrenoceptor stimulation in the isolated perfused hindquarters of the rat: an in vitro model.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1983, Journal of cardiovascular pharmacology.

Hemodynamic Profile of the Cardiotonic Agent Pimobendan

J. V. van Meel, W. Diederen, Jacques C. A. van Meel, 1989, Journal of cardiovascular pharmacology.

Inhibition of Epidermal Growth Factor Receptor Activity by Two Pyrimidopyrimidine Derivatives

K. Heider, A. Baum, F. Solca, 2004, Journal of Pharmacology and Experimental Therapeutics.

Captopril impairs the vascular smooth muscle contraction mediated by postsynaptic alpha 2-adrenoceptors in the pithed rat.

P. Timmermans, B. Wilffert, J. V. van Meel, 1981, European journal of pharmacology.

Calcium antagonists and alpha 2-adrenoceptors: possible role of extracellular calcium ions in alpha 2-adrenoceptor-mediated vasoconstriction.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1982, Journal of cardiovascular pharmacology.

Postsynaptic alpha 1- and alpha 2-adrenoceptor blocking properties of (dihydro)quinidine and (dihydro)quinine.

P. Timmermans, J. V. van Meel, H. Batink, 1983, Arzneimittel-Forschung.

Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine.

P. Timmermans, B. Wilffert, J. V. van Meel, 1983, Pharmacology.

COX-2 Blockade in Cancer Prevention and Therapy,

J. V. van Meel, J. van Ryn, 2003 .

Different types of angiotensin II receptor antagonism induced by BIBS 222 in the rat portal vein and rabbit aorta; the influence of receptor reserve.

J. V. van Meel, M. Pfaffendorf, P. V. van Zwieten, 1994, The Journal of pharmacology and experimental therapeutics.

Central and peripheral alpha-adrenoceptors.

P. Timmermans, B. Wilffert, J. V. van Meel, 1982, Journal of cardiovascular pharmacology.

Different types of receptor interaction of peptide and nonpeptide angiotensin II antagonists revealed by receptor binding and functional studies.

M. Entzeroth, J. V. van Meel, W. Wienen, 1992, Molecular pharmacology.

Characterization of BIBS 39 and BIBS 222: two new nonpeptide angiotensin II receptor antagonists.

M. Entzeroth, J. V. van Meel, W. Wienen, 1992, European journal of pharmacology.

The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs.

J. V. van Meel, W. Wienen, H. Doods, 1993, European journal of pharmacology.

Effects of pimobendan and its metabolite on myofibrillar calcium responsiveness and ATPase activity in the presence of inorganic phosphate.

M. Entzeroth, J. V. van Meel, N. Redemann, 1995, Arzneimittel-Forschung.

Caenorhabditis elegans as model system for rapid toxicity assessment of pharmaceutical compounds.

J. V. van Meel, Marlene Dengg, J. C. V. van Meel, 2004, Journal of pharmacological and toxicological methods.

Effect of captopril on sympathetic neurotransmission in pithed normotensive rats.

P. Timmermans, B. Wilffert, P. van Brummelen, 1983, European journal of pharmacology.

Functional interaction between calcium antagonists and the vasoconstriction induced by the stimulation of postsynaptic alpha 2-adrenoceptors.

P. Timmermans, J. V. van Meel, P. V. van Zwieten, 1983, Circulation Research.

Effect of adrenalectomy and demedullation of the adrenals on vasopressor responses to stimulation of postjunctional alpha 2-adrenoceptors.

P. Timmermans, B. Wilffert, J. V. van Meel, 1983, European journal of pharmacology.

Hypotensive effects of the angiotensin II antagonist telmisartan in conscious chronically-instrumented transgenic rats.

J. V. van Meel, N. Redemann, R. Haigh, 1996, Arzneimittel-Forschung.